An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Description

Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) and compare the results between the two new assessments and the previous "gold standard", the Clinician Administered PTSD Scale for DSM-IV (CAPS-IV). Biomarkers believed to be related to PTSD (e.g., biofluid biomarkers, cognitive and physiological markers, and neural activity as measured by EEG) will be collected to inform targeted interventions in specific groups of patients and other large-scale biomarker discovery efforts in the field. Participants will be 950 male and female active duty military and veterans ages 18 or older who have been exposed to at least one traumatic event.

Conditions

Stress Disorders, Post-Traumatic

Study Overview

Study Details

Study overview

Given the high prevalence of post-traumatic stress disorder (PTSD) in veterans and active duty military, the focus of this research study is to test the reliability of two new PTSD assessments, the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) and compare the results between the two new assessments and the previous "gold standard", the Clinician Administered PTSD Scale for DSM-IV (CAPS-IV). Biomarkers believed to be related to PTSD (e.g., biofluid biomarkers, cognitive and physiological markers, and neural activity as measured by EEG) will be collected to inform targeted interventions in specific groups of patients and other large-scale biomarker discovery efforts in the field. Participants will be 950 male and female active duty military and veterans ages 18 or older who have been exposed to at least one traumatic event.

Psychometric Evaluation of the Clinician Administered PTSD Scale for DSM-5 (CAPS-5) and the PTSD Symptom Scale Interview for DSM-5 (PSSI-5) in an Active Duty and Military Veteran Sample

An Evaluation of Two PTSD Assessments in an Active Duty and Military Veteran Sample

Condition
Stress Disorders, Post-Traumatic
Intervention / Treatment

-

Contacts and Locations

Honolulu

Tripler Army Medical Center, Honolulu, Hawaii, United States, 96859

Fort Thomas

Cincinnati VA Medical Center - Trauma Recovery Center, Fort Thomas, Kentucky, United States, 41075

Bethesda

Walter Reed National Military Medical Center, Bethesda, Maryland, United States, 20814

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * Male or female active duty personnel or military veterans, 18 years of age or older
  • * Competent to give informed consent
  • * Have experienced any Criterion A qualifying traumatic event as defined by the Life Events Checklist for DSM-5 (LEC-5)
  • * Score a 3 or above on the Primary Care-Post Traumatic Stress Disorder Screen (PC-PTSD-5)
  • * Current suicidal or homicidal ideation with a plan, and substance use disorder requiring detoxification currently or in the past month as assessed using the SCID and Suicidal Ideation/Homicidal Ideation screening tool (SI/HI screen)
  • * Assessment using CAPS or PSSI in the previous 1 year
  • * Currently receiving psychotherapy or counseling for PTSD
  • * Moderate to sever cognitive impairment as measured by the Montreal Cognitive Assessment (MoCA)
  • * Meet criteria for unmedicated Bipolar I, Bipolar II, Schizophrenia, or other psychotic disorders in the last month

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

Yes

Collaborators and Investigators

U.S. Army Medical Research and Development Command,

Kathleen M Chard, PhD, PRINCIPAL_INVESTIGATOR, Cincinnati VA Medical Center, University of Cincinnati

Brian Marx, PhD, PRINCIPAL_INVESTIGATOR, National Center for PTSD at VA Boston Healthcare System

Study Record Dates

2025-06-30